XML 29 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated statement of changes in equity/(deficit) - EUR (€)
€ in Millions
Total
Number of Ordinary Shares Outstanding
Share Capital
Treasury Shares
Other Paid in Capital
Other Reserves
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017   167,258,400          
Beginning balance at Dec. 31, 2017 € 238   € 0 € 0 € 2,488 € 177 € (2,427)
Loss for the year (78)   0 0 0 0 (78)
Other comprehensive income (loss) 564   0 0 0 564 0
Issuance of ordinary shares (in shares)   5,776,920          
Issuance of ordinary shares 4   0 0 4 0 0
Repurchases of ordinary shares (in shares)   (6,427,271)          
Repurchases of ordinary shares (77)   0 (77) 0 0 0
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   4,816,072          
Issuance of shares upon exercise of stock options and restricted stock units 163   0 0 163 0 0
Issuance of share-based compensation in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes (2)   0 0 0 (2) 0
Issuance of shares upon exchange of Convertible Notes (in shares)   9,431,960          
Issuance of shares upon exchange of Convertible Notes 1,146   0 0 1,146 0 0
Share-based compensation 88   0 0 0 88 0
Income tax impact associated with share-based payments 48   0 0 0 48 0
Ending balance (Previously stated) at Dec. 31, 2018 2,094   0 (77) 3,801 875 (2,505)
Ending balance (Cumulative effect adjustment in connection with the adoption of IFRS 16) at Dec. 31, 2018 (18)   0 0 0 0 (18)
Ending balance (After adoption of IFRS 16) at Dec. 31, 2018 2,076   0 (77) 3,801 875 (2,523)
Ending balance (in shares) (Previously stated) at Dec. 31, 2018   180,856,081          
Ending balance (in shares) (Cumulative effect adjustment in connection with the adoption of IFRS 16) at Dec. 31, 2018   0          
Ending balance (in shares) (After adoption of IFRS 16) at Dec. 31, 2018   180,856,081          
Loss for the year (186)   0 0 0 0 (186)
Other comprehensive income (loss) € (111)   0 0 0 (111) 0
Repurchases of ordinary shares (in shares) (3,679,156) (3,679,156)          
Repurchases of ordinary shares € (433)   0 (433) 0 0 0
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   3,557,405          
Issuance of shares upon exercise of stock options and restricted stock units 154   0 140 14 0 0
Issuance of shares upon exercise of, or net settlement of, warrants (in shares)   3,591,627          
Issuance of shares upon exercise of, or net settlement of, warrants 377   0 0 377 0 0
Issuance of share-based compensation in conjunction with business combinations 13   0 0 0 13 0
Restricted stock units withheld for employee taxes (6)   0 0 0 (6) 0
Share-based compensation 127   0 0 0 127 0
Income tax impact associated with share-based payments 26   0 0 0 26 0
Ending balance at Dec. 31, 2019 2,037   0 (370) 4,192 924 (2,709)
Ending balance (in shares) at Dec. 31, 2019   184,325,957          
Loss for the year (581)   0 0 0 0 (581)
Other comprehensive income (loss) 577   0 0 0 577 0
Issuance of ordinary shares (in shares)   5,038,200          
Issuance of ordinary shares € 0   0 0 0 0 0
Repurchases of ordinary shares (in shares) (5,038,200) (5,038,200)          
Repurchases of ordinary shares € 0   0 0 0 0 0
Issuance of shares upon exercise of stock options and restricted stock units (in shares)   4,802,847          
Issuance of shares upon exercise of stock options and restricted stock units 319   0 195 124 0 0
Issuance of shares upon exercise of, or net settlement of, warrants (in shares)   1,084,043          
Issuance of shares upon exercise of, or net settlement of, warrants 267   0 0 267 0 0
Issuance of share-based compensation in conjunction with business combinations 0            
Restricted stock units withheld for employee taxes (29)   0 0 0 (29) 0
Share-based compensation 181   0 0 0 181 0
Income tax impact associated with share-based payments 34   0 0 0 34 0
Ending balance at Dec. 31, 2020 € 2,805   € 0 € (175) € 4,583 € 1,687 € (3,290)
Ending balance (in shares) at Dec. 31, 2020   190,212,847